• Arcutis Biotherapeutics (ARQT) Following FDA Acceptance For ZORYVE Is The Upside Still There simplywall.st Fri, 10 Jul 2026 02:21:37 GMT
• Biotech Stock Arcutis Climbs Into Buy Zone As FDA Mulls Expanded Use For Key Skin Treatment Investor's Business Daily Thu, 09 Jul 2026 17:37:00 GMT
• Could Arcutis (ARQT) Infant Label Bid Clarify the Limits of Its Single-Drug Strategy? simplywall.st Wed, 08 Jul 2026 21:37:25 GMT
• BREAKING: US FDA Sets PDUFA for Roflumilast Cream 0.05% in Infants With AD The Dermatology Digest Wed, 08 Jul 2026 20:24:06 GMT
• FDA Accepts sNDA for Roflumilast Cream 0.05% in Infants With Atopic Dermatitis Down to 3 Months Dermatology Times Wed, 08 Jul 2026 19:52:50 GMT
• Arcutis gets FDA review for Zoryve 0.05% label expansion (ARQT) Seeking Alpha Wed, 08 Jul 2026 14:56:25 GMT
• arcutis biotherapeutics (arqt) receives fda acceptance for zoryve cream GuruFocus Wed, 08 Jul 2026 14:20:43 GMT
• FDA accepts Arcutis application for infant eczema treatment Investing.com Wed, 08 Jul 2026 13:35:08 GMT
• Arcutis: FDA to Review Zoryve for Atopic Dermatitis in Infants Moomoo Wed, 08 Jul 2026 12:47:09 GMT
• FDA Accepts Supplemental New Drug Application for Arcutis’ ZORYVE® (roflumilast) Cream 0.05% for the Treatment of Mild to Moderate... The Manila Times Wed, 08 Jul 2026 12:04:47 GMT
• Arcutis wins FDA review for ZORYVE in infants as young as 3 months Stock Titan Wed, 08 Jul 2026 12:00:00 GMT
• Price to sales forward of Arcutis Biotherapeutics, Inc. – NASDAQ:ARQT TradingView Sun, 05 Jul 2026 18:19:05 GMT
• 3 Healthcare Stocks Built For Higher Rates And Steady Demand simplywall.st Sat, 04 Jul 2026 06:30:29 GMT
• Comparative Analysis of Arcutis and Vertex Biotherapeutics Intellectia AI Fri, 03 Jul 2026 14:12:25 GMT
• Arcutis vs. Vertex: Which Pharmaceutical Maker Stock Is a Better Buy in 2026? The Motley Fool Fri, 03 Jul 2026 13:37:00 GMT
• Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) The Manila Times Thu, 02 Jul 2026 20:08:25 GMT
• Needham Maintains Arcutis Biotherapeutics(ARQT.US) With Buy Rating, Maintains Target Price $36 Moomoo Wed, 01 Jul 2026 13:52:53 GMT
• Should ZORYVE’s New Pediatric Label and Virtual Platform Expansion Require Action From Arcutis (ARQT) Investors? simplywall.st Tue, 30 Jun 2026 22:23:30 GMT
• FDA Approves Roflumilast Cream 0.3% for Plaque Psoriasis in Children as Young as 2 Pharmacy Times – Pharmacy Practice News and Expert Insights Tue, 30 Jun 2026 20:39:17 GMT
• Arcutis Launches Virtual Dermatology Platform to Boost Access to Roflumilast The Dermatology Digest Tue, 30 Jun 2026 16:25:23 GMT
• avoiding lag: real-time signals in (arqt) movement Stock Traders Daily Tue, 30 Jun 2026 16:14:02 GMT
• Arcutis launches virtual dermatology platform for skin conditions Investing.com Tue, 30 Jun 2026 14:06:10 GMT
• fda approves expanded use for arcutis’ zoryve cream The Pharma Letter Tue, 30 Jun 2026 13:54:51 GMT
• arcutis launches new virtual health platform supporting access to care for individuals living with chronic inflammatory skin disea... The Manila Times Tue, 30 Jun 2026 13:29:06 GMT
• Arcutis’ new virtual dermatology platform targets care gaps for 45M Americans Stock Titan Tue, 30 Jun 2026 07:00:00 GMT
• arcutis biotherapeutics (arqt) secures fda approval for zoryve c GuruFocus Tue, 30 Jun 2026 01:07:44 GMT
• fda approves zoryve cream for plaque psoriasis in children age 2+ by investing.com Investing.com South Africa Tue, 30 Jun 2026 00:07:56 GMT
• fda approves supplemental nda to expand indication of arcutis’ zoryve cream TipRanks Mon, 29 Jun 2026 23:34:31 GMT
• fda approves zoryve cream for plaque psoriasis in children age 2+ Investing.com Mon, 29 Jun 2026 23:28:13 GMT
• FDA expands roflumilast cream approval to children as young as 2 years with plaque psoriasis Contemporary Pediatrics Mon, 29 Jun 2026 23:26:25 GMT
• fda approves arcutis’ zoryve® (roflumilast) cream 0.3% for the treatment of plaque psoriasis in children as young as age 2 The Manila Times Mon, 29 Jun 2026 23:16:26 GMT
• Arcutis Biotherapeutics Announces FDA Approval of Expanded ZORYVE Cream 0.3% Indication for Children With Plaque Psoriasis Down to... Quiver Quantitative Mon, 29 Jun 2026 23:10:00 GMT
• FDA Approves Roflumilast Cream 0.3% for Plaque Psoriasis Down to Age 2 Dermatology Times Mon, 29 Jun 2026 07:00:00 GMT
• arcutis biotherapeutics (arqt) secures fda approval for zoryve c GuruFocus Mon, 29 Jun 2026 07:00:00 GMT
• a quick look at today's ratings for arcutis biotherapeutics(arqt.us), with a forecast between $34 to $36 Moomoo Fri, 26 Jun 2026 07:00:00 GMT
• arcutis director sells $121,000 in stock as zoryve revenue jumps 65% The Motley Fool Wed, 24 Jun 2026 00:15:00 GMT
• guggenheim maintains arcutis biotherapeutics(arqt.us) with buy rating, maintains target price $35 富途牛牛 Tue, 23 Jun 2026 07:24:06 GMT
• arcutis director sells $121,000 in stock as zoryve revenue jumps 65% The Motley Fool Tue, 23 Jun 2026 07:00:00 GMT
• arcutis biotherapeutics inc (nasdaq:arqt): a garp growth play at a reasonable price ChartMill Mon, 22 Jun 2026 09:30:29 GMT
• arcutis biotherapeutics inc (arqt) financial health: profitability & balance sheet analysis TradingKey Mon, 22 Jun 2026 07:00:00 GMT
• discipline and rules-based execution in arqt response Stock Traders Daily Fri, 19 Jun 2026 15:02:01 GMT
• insider sell alert: sue-jean lin sells shares of arcutis biother GuruFocus Thu, 18 Jun 2026 05:14:10 GMT
• arcutis director sue-jean lin sells $120,586 in company shares Investing.com Thu, 18 Jun 2026 03:04:31 GMT
• arcutis biotherapeutics inc (arqt) institutional confidence TradingKey Thu, 18 Jun 2026 00:59:51 GMT
• arcutis (arqt) director sue-jean lin executes planned share sale Stock Titan Thu, 18 Jun 2026 00:50:06 GMT
• arcutis (arqt) director trades shares under rule 10b5-1 stock plan Stock Titan Thu, 18 Jun 2026 00:44:11 GMT
• arcutis biotherapeutics inc (arqt) technical analysis: support, resistance, indicators & moving averages TradingKey Wed, 17 Jun 2026 23:08:24 GMT
• arcutis biotherapeutics inc (arqt) risk assessment: volatility, financial risk & investment risk TradingKey Wed, 17 Jun 2026 22:53:36 GMT
• arcutis biotherapeutics inc (arqt) financial health: profitability & balance sheet analysis TradingKey Wed, 17 Jun 2026 22:51:54 GMT
• arcutis biotherapeutics inc (arqt) valuation: pe, pb & fair value analysis TradingKey Wed, 17 Jun 2026 22:51:06 GMT
• Arcutis Biotherapeutics Inc (ARQT) Earnings Forecast: Future EPS & Revenue Growth Estimates TradingKey Wed, 17 Jun 2026 22:47:07 GMT
• arcutis biotherapeutics inc (arqt) revenue breakdown: business segments, regional revenue & profit contribution TradingKey Wed, 17 Jun 2026 21:05:13 GMT
• arcutis biotherapeutics inc (arqt) dividends & stock splits: historical payouts and event timeline TradingKey Wed, 17 Jun 2026 21:01:51 GMT
• arcutis biotherapeutics inc (arqt) shareholder structure: major shareholders & institutional holdings TradingKey Wed, 17 Jun 2026 20:28:52 GMT
• Arcutis (ARQT) director trades shares under Rule 10b5-1 stock plan Stock Titan Wed, 17 Jun 2026 07:00:00 GMT
• Insider Sell Alert: Sue-jean Lin Sells Shares of Arcutis Biother GuruFocus Wed, 17 Jun 2026 07:00:00 GMT
• Arcutis (ARQT) director Sue-Jean Lin executes planned share sale Stock Titan Wed, 17 Jun 2026 07:00:00 GMT
• arcutis biotherapeutics inc (arqt) institutional confidence TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• arcutis biotherapeutics inc (arqt) financial health: profitability & balance sheet analysis TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• arcutis biotherapeutics inc (arqt) valuation: pe, pb & fair value analysis TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• Arcutis (ARQT) director amends filing to correct indirect share count Stock Titan Fri, 12 Jun 2026 07:00:00 GMT
• arcutis biotherapeutics touts zoryve growth, fda catalysts and cash-flow positive status MSN Fri, 12 Jun 2026 01:17:03 GMT
• is arcutis (arqt) using genital psoriasis education to quietly reshape its dermatology strategy? Yahoo Finance Fri, 12 Jun 2026 01:15:00 GMT
• arcutis biotherapeutics, inc. (arqt) reports q1 loss, beats revenue estimates MSN Thu, 11 Jun 2026 21:24:44 GMT
• gw&k investment management llc sells 163,461 shares of arcutis biotherapeutics, inc. $arqt MarketBeat Thu, 11 Jun 2026 10:39:48 GMT
• Is Arcutis (ARQT) Using Genital Psoriasis Education to Quietly Reshape Its Dermatology Strategy? Yahoo Finance Thu, 11 Jun 2026 07:00:00 GMT
• arcutis biotherapeutics touts zoryve growth, fda catalysts and cash-flow positive status MSN Thu, 11 Jun 2026 00:03:14 GMT
• is arcutis biotherapeutics (arqt) quietly redefining its risk profile with zoryve momentum and new guidance? simplywall.st Wed, 10 Jun 2026 07:00:00 GMT
• arcutis stockholders approve proposals at 2026 meeting The Globe and Mail Wed, 10 Jun 2026 07:00:00 GMT
• arcutis biotherapeutics (nasdaq:arqt) shares acquired rep. gilbert ray cisneros, jr. MarketBeat Wed, 10 Jun 2026 06:10:34 GMT
• arcutis (arqt) grants director 5,778 rsus and 16,667 options Stock Titan Wed, 10 Jun 2026 01:43:47 GMT
• arcutis (arqt) director receives rsu grant and 16,667-share stock option Stock Titan Wed, 10 Jun 2026 01:43:47 GMT
• arcutis (nasdaq: arqt) director awarded rsus and 16,667-share stock option Stock Titan Wed, 10 Jun 2026 01:43:47 GMT
• [form 4] arcutis biotherapeutics, inc. insider trading activity Stock Titan Wed, 10 Jun 2026 01:38:48 GMT
• arcutis biotherapeutics touts zoryve growth, fda catalysts and cash-flow positive status Yahoo Finance Wed, 10 Jun 2026 00:02:00 GMT
• Arcutis Biotherapeutics Touts ZORYVE Growth, FDA Catalysts and Cash-Flow Positive Status Yahoo Finance Tue, 09 Jun 2026 07:00:00 GMT
• Arcutis Biotherapeutics (ARQT) 2026 meeting OKs directors, auditor and executive pay Stock Titan Tue, 09 Jun 2026 07:00:00 GMT
• [form 4] arcutis biotherapeutics, inc. insider trading activity Stock Titan Tue, 09 Jun 2026 07:00:00 GMT
• arcutis (nasdaq: arqt) director awarded rsus and 16,667-share stock option Stock Titan Tue, 09 Jun 2026 07:00:00 GMT
• arcutis (arqt) director receives rsu grant and 16,667-share stock option Stock Titan Tue, 09 Jun 2026 07:00:00 GMT
• geode capital management llc has $79.97 million stock holdings in arcutis biotherapeutics, inc. $arqt MarketBeat Mon, 08 Jun 2026 08:48:10 GMT
• Assessing Arcutis Biotherapeutics (ARQT) Valuation After New Genital Psoriasis Clinical Guidance Publication simplywall.st Mon, 08 Jun 2026 07:00:00 GMT
• arcutis biotherapeutics reports inducement grants under nasdaq listing rule 5635(c)(4) The Manila Times Sat, 06 Jun 2026 07:00:00 GMT
• earnings call transcript: arcutis biotherapeutics q1 2026 sees revenue beat, eps miss Investing.com Fri, 05 Jun 2026 09:55:10 GMT
• Six new Arcutis hires receive 44,000 restricted stock units Stock Titan Fri, 05 Jun 2026 07:00:00 GMT
• arcutis biotherapeutics reports inducement grants under nasdaq listing rule 5635(c)(4) Yahoo Finance Fri, 05 Jun 2026 07:00:00 GMT
• arcutis grants 44,000 restricted stock units to six new hires as inducement under nasdaq rules. Pluang Fri, 05 Jun 2026 07:00:00 GMT
• arcutis biotherapeutics evp masaru matsuda sells $192k in stock Investing.com Fri, 05 Jun 2026 07:00:00 GMT
• arcutis biotherapeutics svp cfo latha vairavan sells $31,661 in stock Investing.com Fri, 05 Jun 2026 07:00:00 GMT
• arcutis q1 2026 slides: revenue surges 65% as zoryve gains share Investing.com Fri, 05 Jun 2026 07:00:00 GMT
• arcutis biotherapeutics evp masaru matsuda sells $192k in stock Investing.com Thu, 04 Jun 2026 15:28:01 GMT
• Mizuho Securities Maintains Arcutis Biotherapeutics(ARQT.US) With Buy Rating, Maintains Target Price $35 Moomoo Wed, 03 Jun 2026 07:00:00 GMT
• new age-based genital psoriasis guidelines target missed diagnoses Stock Titan Wed, 03 Jun 2026 07:00:00 GMT
• new expert consensus provides age-specific guidance for improving care for individuals with genital psoriasis published in the ame... The Manila Times Wed, 03 Jun 2026 07:00:00 GMT
• hillsdale investment management inc. invests $5.21 million in arcutis biotherapeutics, inc. $arqt MarketBeat Sun, 31 May 2026 10:09:57 GMT
• arqt financials: revenue breakdown, margins & competitor comparison Intellectia AI Sun, 31 May 2026 02:29:15 GMT
• td cowen maintains arcutis biotherapeutics(arqt.us) with buy rating, maintains target price $35 富途牛牛 Fri, 29 May 2026 06:11:05 GMT
• a quick look at today's ratings for arcutis biotherapeutics(arqt.us), with a forecast between $34 to $36 富途牛牛 Fri, 29 May 2026 03:53:08 GMT
• (arqt) movement within algorithmic entry frameworks Stock Traders Daily Thu, 28 May 2026 12:24:02 GMT
• analysts have conflicting sentiments on these healthcare companies: bicara therapeutics inc. (bcax), abivax sa sponsored adr (abvx... The Globe and Mail Wed, 27 May 2026 07:00:00 GMT
• a quick look at today's ratings for arcutis biotherapeutics(arqt.us), with a forecast between $34 to $37 Moomoo Wed, 27 May 2026 05:22:39 GMT
• Arcutis Management to Present at Goldman Sachs 47th Annual Global Healthcare Conference Yahoo Finance Tue, 26 May 2026 07:00:00 GMT
• Insiders At Arcutis Biotherapeutics Sold US$4.4m In Stock, Alluding To Potential Weakness Moomoo Tue, 26 May 2026 07:00:00 GMT
• biotech arcutis joins goldman sachs healthcare talks in miami, streaming online Stock Titan Tue, 26 May 2026 07:00:00 GMT
• arcutis biotherapeutics (arqt) edges lower as shares test key support levels - volatility surface Město Břeclav Mon, 25 May 2026 07:00:00 GMT
• is strong q1 growth and reaffirmed guidance altering the investment case for arcutis biotherapeutics (arqt)? Sahm Tue, 19 May 2026 09:07:58 GMT
• is strong q1 growth and reaffirmed guidance altering the investment case for arcutis biotherapeutics (arqt)? simplywall.st Mon, 18 May 2026 07:00:00 GMT
• arcutis biotherapeutics earns relative strength rating upgrade; hits key benchmark MSN Sun, 17 May 2026 20:31:07 GMT
• how (arqt) movements inform risk allocation models Stock Traders Daily Sun, 17 May 2026 07:00:00 GMT
• arcutis biotherapeutics earns relative strength rating upgrade; hits key benchmark MSN Sat, 16 May 2026 23:43:08 GMT
• arcutis biotherapeutics (arqt) price target increased by 32.62% to 31.62 MSN Sat, 16 May 2026 20:39:35 GMT
• number of shareholders of arcutis biotherapeutics, inc. – nasdaq:arqt TradingView Fri, 15 May 2026 12:52:38 GMT
• Arcutis Biotherapeutics: The Dermatology Platform Is Starting To Compound (NASDAQ:ARQT) Seeking Alpha Fri, 15 May 2026 07:00:00 GMT
• arcutis biotherapeutics, inc. - common stock (nq: arqt FinancialContent Fri, 15 May 2026 03:02:02 GMT
• arcutis biotherapeutics (arqt) price target increased by 32.62% to 31.62 MSN Thu, 14 May 2026 11:09:59 GMT
• arcutis biotherapeutics svp cfo latha vairavan sells $9,156 in stock. by investing.com Investing.com UK Thu, 14 May 2026 07:00:00 GMT
• arcutis evp, cmo burnett sells $4,673 in common stock by investing.com Investing.com Nigeria Thu, 14 May 2026 00:29:24 GMT
• first child enrolled in arcutis’ phase ii trial of cream for atopic dermatitis MSN Wed, 13 May 2026 22:48:47 GMT
• arcutis biotherapeutics (arqt) officer sells 222 shares to cover rsu tax Stock Titan Wed, 13 May 2026 07:00:00 GMT
• arcutis (arqt) cfo tax-related sale of 435 shares after rsu vesting Stock Titan Wed, 13 May 2026 07:00:00 GMT
• arcutis biotherapeutics svp cfo latha vairavan sells $9,156 in stock. Investing.com Wed, 13 May 2026 07:00:00 GMT
• arqt stock chart | arcutis biotherapeutics inc (nasdaq:arqt) ChartMill Wed, 13 May 2026 07:00:00 GMT
• arcutis q1 2026 slides: revenue surges 65% amid expansion push by investing.com Investing.com Nigeria Wed, 13 May 2026 01:49:28 GMT
• State Street (NYSE: STT) holds 6.30M shares of Arcutis (5.1%) Stock Titan Tue, 12 May 2026 07:00:00 GMT
• arcutis q1 2026 slides: revenue surges 65% amid expansion push Investing.com Tue, 12 May 2026 07:00:00 GMT
• earnings call transcript: arcutis biotherapeutics q1 2026 misses eps expectations Investing.com Australia Tue, 12 May 2026 07:00:00 GMT
• arqt stock price, quote & chart | arcutis biotherapeutics inc (nasdaq:arqt) ChartMill Tue, 12 May 2026 07:00:00 GMT
• H.C. Wainwright Maintains Arcutis Biotherapeutics(ARQT.US) With Buy Rating, Maintains Target Price $34 Moomoo Mon, 11 May 2026 07:00:00 GMT
• arcutis biotherapeutics (arqt) form 144: patrick burnett reports share dispositions Stock Titan Mon, 11 May 2026 07:00:00 GMT
• arcutis biotherapeutics (arqt) form 144 lists 435 vested shares for resale Stock Titan Mon, 11 May 2026 07:00:00 GMT
• a look at arcutis biotherapeutics (arqt) valuation after q1 2026 results and zoryve label expansion efforts simplywall.st Mon, 11 May 2026 07:00:00 GMT
• fda approval for zoryve issued to arcutis biotherapeutics inc Quantisnow Sat, 09 May 2026 14:33:53 GMT
Arcutis Biotherapeutics, Inc(NASDAQ:ARQT) 
Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atop...
Website: http://www.arcutis.com
Founded: 2016
Full Time Employees: 53
CEO: Todd Franklin Watanabe
Sector: Healthcare
Industry: Biotechnology